Testing, Information Access
|Many question whether the initiative can adequately address issues of privacy and the need for education.|
IN FAVOR: OncorMed's Doug Dolginow believes his firm will benefit from the network.
The network is conceived as a "two-way street," says...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!